"World-Class Retina Care - The Valley Retina Institute Welcome to the new home of the Valley Retina Institute. We provide all the same care and the same doctors you’ve come to love from Valley Retina Institute across our Gulf Coast Eye locations! No matter what your retinal issue is, we have experts who can guide you through treatment and recovery. We have a department devoted to clinical research as it relates to eye conditions and innovative treatments, with special emphasis on the retina. Our dedicated research team searches out studies/trials that have notable patient benefits and help us provide exceptional care."

During the past decade, Valley Retina Institute conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 27 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 17 clinical trials were completed. i.e. 68% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Valley Retina Institute" #1 sponsor was "Jaeb Center for Health Research" with 13 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "ThromboGenics" with 6 trials sponsored, "Apellis Pharmaceuticals, Inc." with 3 trials sponsored and "Bausch & Lomb Incorporated" with 3 trials sponsored. Other sponsors include 47 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Valley Retina Institute" #1 collaborator was "National Eye Institute (NEI)" with 12 trials as a collaborator, "Regeneron Pharmaceuticals" with 5 trials as a collaborator, "Genentech, Inc." with 4 trials as a collaborator, "Allergan" with 3 trials as a collaborator and "National Institutes of Health (NIH)" with 3 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Valley Retina Institute" are "Diabetic Macular Edema" (22 trials), "Diabetic Retinopathy" (15 trials), "Geographic Atrophy" (8 trials), "Macular Degeneration" (8 trials) and "Retinal Vein Occlusion" (6 trials). Many other conditions were trialed in "Valley Retina Institute" in a lesser frequency.

Most popular intervention types in "Valley Retina Institute" are "Drug" (75 trials), "Other" (15 trials), "Procedure" (8 trials), "Biological" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Sham Procedure" (8 trials), "Sham" (6 trials), "Aflibercept" (4 trials) and "Faricimab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Valley Retina Institute" are 84 trials for "All" genders.

Currently, there are NaN active trials in "Valley Retina Institute". undefined are not yet recruiting, 9 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 50 completed trials in Valley Retina Institute, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Valley Retina Institute, 12 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 2 trials that are defined as “Not Applicable".